Company Search:
Advanced Search
Sponsored Links
Amphastar Pharmaceuticals Inc Company Snapshot
Amphastar Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amphastar Pharmaceuticals Inc with three other companies in this sector in the United States: Assertio Therapeutics Inc (2018 sales of $311.77 million of which 100% was Pharmasuticals), Collegium Pharmaceutical Inc ($280.41 million of which 75% was Nucynta), and Sarepta Therapeutics Incorporated ($301.03 million of which 100% was Grants & Research).

Sales Analysis. Amphastar Pharmaceuticals Inc reported sales of $294.67 million for the year ending December of 2018. This represents an increase of 22.7% versus 2017, when the company's sales were $240.18 million. Sales of Api saw an increase that was more than double the company's growth rate: sales were up 135.2% in 2018, from $10.04 million to $23.61 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Amphastar Pharmaceuticals Inc
  Stock Performance Chart for Amphastar Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 18.41
(Figures in U.S. Dollars)
1 Week -5.9%   13 Weeks -6.9%  
4 Weeks -10.8%   52 Weeks -14.7%  
Amphastar Pharmaceuticals Inc Key Data:
  Ticker: AMPH Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 294,666,000
(Year Ending Jan 2019).
Employees: 2,078
  Currency: U.S. Dollars Market Cap: 868,950,288
  Fiscal Yr Ends: December Shares Outstanding: 47,199,907
  Share Type: Common Closely Held Shares: 11,836,159
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.